Xenon Pharmaceuticals Inc (XENE) — Cash Flow Quality Index

Latest as of December 2014: -2.41x

Xenon Pharmaceuticals Inc (XENE) has a Cash Flow Quality Index of -2.41x as of December 2014. Operating cash flow of $-2.95 Million is below net income of $1.22 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of Xenon Pharmaceuticals Inc to assess how effectively this company generates cash.

Cash Flow Quality Index

-2.41x
Operating CF / Net Income

Operating Cash Flow

$-2.95 Million
USD

Net Income

$1.22 Million
USD

Data as of

Dec 2014
Most recent filing

Xenon Pharmaceuticals Inc Cash Flow Quality Index (2013–2014)

Historical Cash Flow Quality Index for Xenon Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Xenon Pharmaceuticals Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Xenon Pharmaceuticals Inc (2013–2014)

Year-by-year earnings quality comparison for Xenon Pharmaceuticals Inc. For live market cap and the full company financial profile, see market value of Xenon Pharmaceuticals Inc.

Year Quality Index Operating CF (USD) Net Income YoY Change
2014 0.02x $266.00K $13.02 Million ▲ +107.4%
2013 -0.28x $-3.32 Million $12.03 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.